| Filed On | Filing |
|---|---|
| 14 May 2026 |
Form 3: Oramed Pharmaceuticals Inc., 10% owner · Lifeward Ltd
Holds 1,250,363 shares of Ordinary Shares |
| 21 Jun 2024 |
Form 3: Gabay Avraham, Chief Financial Officer
No securities owned |
| 02 Apr 2024 |
Form 3: Reznick Yehuda, Director
No securities owned |
| 02 Jan 2024 |
Form 3: Aghion Daniel, Director
No securities owned |
| 01 May 2023 |
Form 3: Shapiro Benjamin, Director
Holds 1,900,000 shares of Common Stock |
| 04 Apr 2022 |
Form 3: Rozov Yadin, Director
No securities owned |
| 11 Jan 2022 |
Form 3: Derovan Netanel, Chief Legal Officer
No securities owned |
| 04 Aug 2021 |
Form 3: Rabinowitz Michael, Chief Commercial Officer
No securities owned |
| 08 Jul 2021 |
Form 3: Silberman David, Chief Financial Officer
No securities owned |
| 11 Dec 2019 |
Form 3: Mayer Arie, Director
Holds 3,000 shares of Common Stock |
| 16 Sep 2019 |
Form 3: Hexter Joshua, Chf. Op. & Bus. Officer
Holds 70,000 shares of Common Stock |
| 19 Jul 2019 |
Form 3: Xiaoming Gao, Director
Holds 1,155,367 shares of Common Stock |
| 05 Jun 2019 |
Form 3: Gabay Avraham, CFO, Treasurer and Secretary
No securities owned |
| 20 Nov 2018 |
Form 3: Hasleton Mark Daniel, VP Business Development
No securities owned |
| 03 Aug 2017 |
Form 3: Eisenberg Hilla, CFO, Treasurer and Secretary
Holds 1,000 shares of COMMON STOCK |
| 21 Mar 2017 |
Form 3: Law Ronald Edward, Chief Strategy Officer
No securities owned |
| 08 Sep 2016 |
Form 3: Rakin Kevin, Director
No securities owned |
| 08 Sep 2016 |
Form 3: Friedman Aviad, Director
Holds 9,691 shares of Common Stock |
| 08 Sep 2016 |
Form 3: Slager David Mark, Director
Holds 1,186,823 shares of Common Stock |
| 27 Jan 2016 |
Form 3: Li Xiaopeng, Director
No securities owned |
Loading...
